iproniazid has been researched along with mannitol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kokosov, AN; Kushelevskiĭ, BP | 1 |
| Burberi, P; Piccinelli, D; Silvestrini, B | 1 |
1 review(s) available for iproniazid and mannitol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for iproniazid and mannitol
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
[Some problems of the differentiated pathogenic therapy of angina pectoris of varied origin].
Topics: Angina Pectoris; Anticoagulants; Brain Concussion; Brain Diseases; Cholecystitis; Coronary Disease; Gallbladder Diseases; Ganglionic Blockers; Gastrointestinal Diseases; Hernia, Diaphragmatic; Humans; Hypertension; Hypnotics and Sedatives; Iproniazid; Kidney Calculi; Mannitol; Muscles; Neurotic Disorders; Phenothiazines; Reserpine; Tranquilizing Agents | 1968 |
Effects of systemically administered drugs on intraocular pressure in rabbits.
Topics: Acetazolamide; Amphetamine; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Blood Pressure; Carbonic Anhydrase Inhibitors; Carotid Arteries; Chlordiazepoxide; Chlorothiazide; Chlorpromazine; Depression, Chemical; Dichlorphenamide; Female; Glycerol; Guanethidine; Hexamethonium Compounds; Imipramine; Intraocular Pressure; Iproniazid; Male; Mannitol; Phenoxybenzamine; Phenylbutazone; Pilocarpine; Pyridines; Rabbits; Stimulation, Chemical; Urea | 1970 |